Educational background and previous brain injury may be associated with higher risk of frontotemporal dementia

by University of Eastern FinlandCredit: Unsplash/CC0 Public DomainTwo recent studies from the University of Eastern Finland show that educational background and previous traumatic brain injury ma

Updated on: June 24,2024 7

Educational background and previous brain injury may be associated with higher risk of frontotemporal dementia

by University of Eastern FinlandCredit: Unsplash/CC0 Public DomainTwo recent studies from the University of Eastern Finland show that educational background and previous traumatic brain injury ma

Updated on:June 24,2024 7

Waste management in the brain may shed light on dementia

by Jim Shelton,Yale UniversityFig. 1: CSF flow speed becomes hyperdynamic with severe CAA. Credit:Nature Aging(2022). DOI: 10.1038/s43587-022-00181-4A new study suggests that a contr

Updated on: May 18,2024 4

Waste management in the brain may shed light on dementia

by Jim Shelton,Yale UniversityFig. 1: CSF flow speed becomes hyperdynamic with severe CAA. Credit:Nature Aging(2022). DOI: 10.1038/s43587-022-00181-4A new study suggests that a contr

Updated on:May 18,2024 4

Use of prescription analgesics differs significantly between persons with and without Alzheimer's

by University of Eastern FinlandApproximately one third of persons with Alzheimer's disease use prescription medicines for pain after their diagnosis, reports a recent study conducted at the

Updated on: March 07,2024 16

Use of prescription analgesics differs significantly between persons with and without Alzheimer's

by University of Eastern FinlandApproximately one third of persons with Alzheimer's disease use prescription medicines for pain after their diagnosis, reports a recent study conducted at the

Updated on:March 07,2024 16

Allopurinol may cut risk for neurodegenerative diseases

by Elana GotkineXanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 inPLOS ONE.Yizhe Song, from the Washingto

Updated on: February 05,2024 13

Allopurinol may cut risk for neurodegenerative diseases

by Elana GotkineXanthine dehydrogenase/oxidase blockers may reduce the risk for neurodegenerative diseases, according to a study published online May 17 inPLOS ONE.Yizhe Song, from the Washingto

Updated on:February 05,2024 13

The way the brain processes speech could serve as a predictor of early dementia

by Baycrest Centre for Geriatric CareCredit: CC0 Public DomainEarly dementia is typically associated with memory and thinking problems; but older adults should also be vigilant about hearing and

Updated on: May 13,2024 7

The way the brain processes speech could serve as a predictor of early dementia

by Baycrest Centre for Geriatric CareCredit: CC0 Public DomainEarly dementia is typically associated with memory and thinking problems; but older adults should also be vigilant about hearing and

Updated on:May 13,2024 7

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on: February 28,2024 20

Drug discovery paradigm targets Tau protein aggregation linked to the Alzheimer's disease

by Bentham Science PublishersDementia and other tauopathies, most notably Alzheimer's disease, embody a class of neurodegenerative diseases associated with the aggregation of the Tau protein in th

Updated on:February 28,2024 20

Using tau imaging as diagnostic marker for Alzheimer disease

by The JAMA Network JournalsThe accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tra

Updated on: March 07,2024 20

Using tau imaging as diagnostic marker for Alzheimer disease

by The JAMA Network JournalsThe accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tra

Updated on:March 07,2024 20

Abnormal proteins in the gut could contribute to the development of Alzheimer's disease

by The Physiological SocietyPET scan of a human brain with Alzheimer's disease. Credit: public domainA new study published in theJournal of Physiologyhas shown that misfolded prot

Updated on: May 05,2024 10

Abnormal proteins in the gut could contribute to the development of Alzheimer's disease

by The Physiological SocietyPET scan of a human brain with Alzheimer's disease. Credit: public domainA new study published in theJournal of Physiologyhas shown that misfolded prot

Updated on:May 05,2024 10

How an Alzheimer's-related protein forms plaques

by Leiden UniversityCredit: Leiden UniversityNeurological diseases such as Alzheimer's disease are characterised by aggregates of protein in the brain. The connection of these aggregates to t

Updated on: March 09,2024 11

How an Alzheimer's-related protein forms plaques

by Leiden UniversityCredit: Leiden UniversityNeurological diseases such as Alzheimer's disease are characterised by aggregates of protein in the brain. The connection of these aggregates to t

Updated on:March 09,2024 11

Intranasal insulin may have pro-cognitive benefits

by Elana GotkineIntranasal insulin (INI) seems to have a beneficial effect on global cognition among patients with Alzheimer's disease (AD)/mild cognitive impairment (MCI), according to a review p

Updated on: March 09,2024 10

Intranasal insulin may have pro-cognitive benefits

by Elana GotkineIntranasal insulin (INI) seems to have a beneficial effect on global cognition among patients with Alzheimer's disease (AD)/mild cognitive impairment (MCI), according to a review p

Updated on:March 09,2024 10

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on: March 24,2024 14

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on:March 24,2024 14

Landmark editorial identifies microbes as major cause of Alzheimer's disease

by Joe Paxton,University of ManchesterDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A worldwide team of senior scientists and clinicians have com

Updated on: February 28,2024 19

Landmark editorial identifies microbes as major cause of Alzheimer's disease

by Joe Paxton,University of ManchesterDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A worldwide team of senior scientists and clinicians have com

Updated on:February 28,2024 19